Role of myocardial contrast echocardiography during nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy  by Nagueh, Sherif F et al.
HYPERTROPHIC CARDIOMYOPATHY
Role of Myocardial Contrast Echocardiography During
Nonsurgical Septal Reduction Therapy for Hypertrophic
Obstructive Cardiomyopathy
SHERIF F. NAGUEH, MD, NASSER M. LAKKIS, MD, ZUO-XIANG HE, MD,
KATHERINE J. MIDDLETON, RCT, DONNA KILLIP, RN, WILLIAM A. ZOGHBI, MD, FACC,
MIGUEL A. QUIN˜ONES, MD, FACC, ROBERT ROBERTS, MD, FACC,
MARIO S. VERANI, MD, FACC, NEAL S. KLEIMAN, MD, FACC,
WILLIAM H. SPENCER III, MD, FACC
Houston, Texas
Objectives. This study was undertaken to evaluate the ability of
myocardial contrast echocardiography (MCE) to guide the tar-
geted delivery of ethanol during nonsurgical septal reduction
therapy (NSRT) and to assess the relation between the MCE risk
area and infarct size determined by enzymatic and radionuclide
methods.
Background. NSRT with intracoronary ethanol is a new prom-
ising treatment for patients with hypertrophic obstructive cardio-
myopathy (HOCM). Proper localization and quantification of the
septal infarct before ethanol injection are highly desirable. MCE
can provide accurate delineation of the vascular territory of the
coronary arteries.
Methods. Twenty-nine patients with HOCM and maximal med-
ical therapy underwent NSRT. The left ventricular outflow tract
(LVOT) gradient by Doppler echocardiography at baseline was
53 6 16 mm Hg (mean 6 SD). Before NSRT, MCE was performed
in all patients with intracoronary sonicated albumin (Albunex).
Diluted sonicated albumin (Albunex) was selectively injected into
the septal perforator arteries during simultaneous transthoracic
imaging. Immediately after MCE, ethanol was injected into the
same vessel. Plasma total creatine kinase (CK), total CK-MB
fraction and CK-MB fraction subforms were measured at baseline
and serially for 36 h.
Results. LVOT gradient decreased to 12 6 6 mm Hg (p < 0.001)
after NSRT. Accurate mapping of the vascular beds of the septal
perforators was successfully attained in all patients by MCE.
Furthermore, the MCE risk area correlated well with peak CK
(r 5 0.79, p < 0.001). Six weeks after NSRT, 23 patients
underwent myocardial perfusion studies performed with single-
photon emission computed tomography (SPECT). Mean SPECT
septal perfusion defect size involved 9.5 6 6% of the left ventricle
and correlated well with MCE area (r 5 0.7), with no statistically
significant difference between the risk area estimated by MCE and
that by SPECT.
Conclusions. Estimation of the size of the septal vascular
territory with MCE is accurate, safe and feasible in essentially all
patients during NSRT. MCE can delineate the perfusion bed of
the septal perforators and can predict the infarct size that follows
ethanol injection.
(J Am Coll Cardiol 1998;32:225–9)
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Hypertrophic cardiomyopathy is a relatively common cardiac
disorder that can cause heart failure, angina, syncope and
sudden death. Dynamic left ventricular outflow tract (LVOT)
obstruction through asymmetric septal hypertrophy and sys-
tolic anterior motion of the mitral vale contributes to these
symptoms in many patients with this disease. Patients who
remain symptomatic despite optimal medical therapy are left
with the options of atrioventricular sequential pacing, surgical
myotomy or myectomy (1). However, surgical treatment has its
morbidity and mortality (1). Recently, Sigwart et al. (2) and
Seggewiss et al. (3) described a nonsurgical approach for
hypertrophic obstructive cardiomyopathy (HOCM), with intra-
coronary ethanol injection into the septal arteries, and re-
ported a significant reduction in the outflow gradient (3,4),
thus avoiding the risks of open heart surgery. Because the
septum is perfused through a number of septal perforators,
with significant individual variation and overlap in distribution,
exact delineation of the vascular bed perfused by each perfo-
rator artery is important to determine the vessel or vessels that
should receive the ethanol injection. This targeted delivery of
ethanol to induce a localized selective infarction of the hyper-
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trophied septal segment responsible for the outflow obstruc-
tion should optimize nonsurgical septal reduction therapy
(NSRT) and possibly minimize the risk of complete heart
block. Sonicated albumin, an echocardiographic contrast
agent, has rheologic characteristics similar to that of red blood
cells (5), with a strictly intravascular distribution and can
provide quantitative assessment of the extent of myocardium
supplied by each septal perforator. Accordingly, myocardial
contrast echocardiography (MCE) with sonicated albumin
selectively injected into the septal perforator artery can poten-
tially provide an excellent definition of the vascular bed
perfused by this vessel and can delineate the area at risk before
induced infarction. In this report we describe the use of MCE
in patients undergoing NSRT. In addition, the ability of MCE
to predict infarct size is compared with cardiac enzyme assays
and left ventricular perfusion defects on single-photon emis-
sion computed tomographic (SPECT) myocardial scintigraphy.
Methods
Patients. Twenty-nine patients with symptomatic HOCM
(4 in New York Heart Association functional class II, 19 in
class III, 6 in class IV) receiving maximal medical therapy were
enrolled consecutively. The research protocol was approved by
the institutional review board of Baylor College of Medicine.
All patients provided written informed consent before partic-
ipation. Subjects had to have evidence of asymmetric septal
hypertrophy (basal septal thickness $1.5 cm; ratio of septal
thickness to posterior wall thickness $1.3) with a dynamic
LVOT gradient at the site of systolic anterior motion of the
mitral valve of $40 mm Hg at rest or $60 mm Hg during
dobutamine challenge (maximal dose 40 mg/kg body weight per
min).
MCE studies. Coronary angiography was performed in all
patients to exclude significant atherosclerotic coronary artery
disease. Projections chosen were those that permitted the best
definition of the origin and course of the septal perforator
arteries. A 0.014-in. guide wire was then passed into the
largest, most proximal septal branch, and a short, small angio-
plasty balloon (usually 10 3 2 mm) was subsequently advanced
over the wire. Before ethanol injection, MCE with intracoro-
nary sonicated albumin (Albunex) was performed. Simulta-
neous continuous imaging was performed with an Accuson
XP-128 ultrasound system with a fundamental frequency of
2.5 MHz using standard views. The apical views (four-chamber
and apical long) were selected to allow determination of the
spatial extent of myocardial opacification and to determine the
outflow gradient by Doppler echocardiography. These views
were supplemented in some patients with the parasternal
short- and the parasternal long-axis views. The studies were
taped on 0.5-in. VHS videotape for subsequent playback and
analysis. One to 1.5 ml of sonicated albumin (Albunex) diluted
with normal saline (range of dilution 1:3 to 1:1) to optimize
myocardial enhancement and minimize attenuation was in-
jected into the central lumen of the balloon, followed by a 3-ml
saline flush. After optimization, the gain settings were un-
changed. After localization of the area to be infarcted, 2 to
5 ml of absolute ethanol was injected through the central
lumen of the inflated balloon. The alcohol was left in place for
5 min. The balloon catheter was then flushed with saline, and
the balloon was deflated and removed. Echocardiographic
imaging began a few cardiac cycles before contrast injection,
through its washout and continuously until the ethanol was
flushed. Blood was withdrawn for total creatine kinase (CK),
CK-MB fraction and MB isoforms before NSRT and then at
intervals until the total CK became normal. Cardiac enzymatic
assays were performed using electrophoresis with a technique
previously developed and validated at our institution (6).
SPECT myocardial scintigraphy. Six weeks after the pro-
cedure, patients underwent stress (exercise or adenosine)
thallium-201 SPECT. The SPECT studies were performed
using methods previously reported from our laboratory (7). A
large field of view rotating gamma camera with a high resolu-
tion parallel-hole collimator was used. Thirty-two frames were
acquired over a 180° arc. The images were reconstructed using
a filtered back-projection algorithm and Butterworth filter with
a cutoff frequency of 0.5 Nyquist and an order of 5. Recon-
structed tomograms were then reoriented in the standard
short-, horizontal long- and vertical long-axes for interpreta-
tion and quantitation. Thallium-201 images were quantitated
by experienced nuclear cardiologists who had no knowledge of
any other patient data. Defect size was derived by the polar
map method (7). The raw polar maps for each patient were
statistically compared with the corresponding normal data
bank to determine the left ventricular perfusion defect size and
the extent of scar and ischemia, if present.
Echocardiographic analysis. Echocardiographic analysis
was performed off-line using a Digisonics work station
(EC500) equipped with Doppler and two-dimensional analysis
software by an observer blinded to the CK levels and the
nuclear data. Continuous wave Doppler was used to assess the
LVOT gradient using the modified Bernoulli equation before
and after ethanol injection in the catheterization laboratory
(8). The length of the septum opacified by MCE was measured
from the long axis of the left ventricle and expressed as a
percentage of the septal length from base to apex. The left
ventricle was divided into the 16 segments according to the
American Society of Echocardiography, where the anterior
septum has three segments. The risk area size by MCE
(percent of total left ventricle) was calculated as the length of
the septum opacified by MCE divided by total septal length
Abbreviations and Acronyms
CK 5 creatine kinase
HOCM 5 hypertrophic obstructive cardiomyopathy
LAD 5 left anterior descending coronary artery
LVOT 5 left ventricular outflow tract
MCE 5 myocardial contrast echocardiography (echocardiographic)
NSRT 5 nonsurgical septal reduction therapy
SPECT 5 single-photon emission computed tomography (tomographic)
226 NAGUEH ET AL. JACC Vol. 32, No. 1
MCE DURING NSRT July 1998:225–9
multiplied by 3⁄16. In addition, the opacified area of the septum
in the apical views was planimetered. Subsequently, the area of
the septum opacified by ethanol was planimetered.
Statistics. Continuous data are presented as mean vol-
ume 6 SD. A two-tailed paired t test was used to compare the
LVOT gradients at baseline and after ethanol injection in the
catheterization laboratory. A two-tailed paired t test was also
used to compare the MCE risk area (percent of total left
ventricle) and the SPECT perfusion defect. Linear regression
analysis was used to correlate each of the MCE absolute and
relative risk areas (percentage of the left ventricle) with peak
CK, perfusion defect by SPECT and the septal area opacified
by ethanol. Regression analysis was also used to correlate the
MCE measurements with the reduction in the left LVOT
gradient. Kappa statistics were used to evaluate the agreement
between MCE and SPECT with respect to the extent of septal
infarction. A p value # 0.05 was considered significant.
Results
Patient characteristics. The mean age of the 29 patients
enrolled was 54 6 15 years (range 31 to 83; 14 men, 15
women). All patients had dyspnea, angina or syncope, and all
were receiving beta-adrenergic blocking agents or calcium
channel antagonists, or both. All patients had rest dynamic
gradients, except for four patients who had only provocable
gradients with dobutamine infusion. The mean gradient at
baseline was 53 6 16 mm Hg, which decreased to 12 6
6 mm Hg (p , 0.001) immediately after ethanol injection.
Clinical outcomes. Six weeks after the procedure, the
mean rest LVOT gradient was 9 6 20 mm Hg (p , 0.01), and
25 patients were functional class I, and 4 were class II, with
only 4 still receiving medications. All patients had transient
chest pain during the procedure. The mean hospital stay was
3.6 6 1.7 days, and although 10 patients developed complete
heart block after the procedure, only 8 were pacemaker
dependent at 6 weeks. There were no episodes of sustained
ventricular tachycardia or ventricular fibrillation. There were
no deaths during the procedure or at follow-up.
MCE during NSRT. All patients tolerated sonicated albu-
min (Albunex) injections without hemodynamic or allergic
reactions and without rhythm disturbances. Figures 1 and 2
show myocardial opacification using sonicated albumin in two
patients. In all patients MCE localized the septal territory and
ensured that balloon inflation prevented retrograde spillage
into the left anterior descending coronary (LAD) artery be-
cause the septum was the only opacified wall. In one patient
with an aberrant origin of a septal perforator from a diagonal
branch of the LAD, the opacification of the lateral wall in
addition to the septum precluded ethanol administration.
Once septal localization was attained and the culprit septal
segments were opacified with MCE, ethanol was injected.
Figure 1. MCE of the septum at baseline and
after injection of sonicated albumin (Contrast)
and ethanol. Injections were into the first septal
perforator. The contrast effect with ethanol has
the same distribution as that of the sonicated
albumin.
Figure 2. MCE of the septum at baseline and
after injection of sonicated albumin (Contrast)
and ethanol in another patient. Injection was into
the second septal perforator. Note the opacifica-
tion of the entire septal thickness with both
contrast agents.
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Ethanol was not delivered to the cannulated artery if that
artery did not supply the septal segments causing the LVOT
gradient. Ethanol injection resulted in a significant contrast
effect that was even brighter than that achieved with sonicated
albumin (Fig. 1 and 2). The ethanol-opacified myocardial
territory was identical to that delineated by sonicated albumin
(r 5 0.95, SEE 0.06, p , 0.001). The LVOT dynamic gradient
was then measured again by Doppler echocardiography. If the
gradient did not resolve, or if there was partial opacification of
the segments responsible for the obstruction, the second
largest septal perforator was cannulated. Sonicated albumin
was again injected into this artery to determine the myocardial
bed and in four patients revealed an overlap with the bed of the
proximal vessel. Opacification of the proximal septum was
observed in 22 patients, and both the proximal and mid
segments of the septum were opacified in 7.
MCE and peak CK. Mean peak plasma CK was 1,937 6
848 IU/liter (range 591 to 4,230). On average, 33% of the
septum was opacified (range 20% to 61%), with a mean area of
4.6 6 1.9 cm2 (range 1.32 to 9.3) corresponding to 7.8 6 2% of
the left ventricle (range 3.7% to 11.5%). Significant correla-
tions were present between each of the relative and absolute
risk area by MCE and peak CK (area percent: r 5 0.65;
absolute area: r 5 0.79, p , 0.001 for both) (Fig. 3). Patients
with a larger reduction in outflow gradient had a greater area
of myocardial opacification by MCE (contrast area vs. gradient
reduction: r 5 0.48, p 5 0.012)
MCE and perfusion defects by SPECT. Twenty-three pa-
tients had SPECT studies at 6 weeks after NSRT. The other six
patients refused to undergo stress testing. The stress modality
was exercise in 20 patients and adenosine in 3. Fixed perfusion
defects were present in all patients. Thirteen patients had
proximal septal defects, and 10 had defects beyond the proxi-
mal septum. There was 87% agreement in the localization of
perfusion abnormalities in the septum between MCE and
SPECT (kappa 0.72). Mean defect size by SPECT was 9.5 6
6% (range 3% to 27%), similar to that obtained by MCE (p 5
0.12). Significant correlations were present between MCE risk
area and nuclear SPECT perfusion defect size (MCE area
percent: r 5 0.54, p 5 0.02; absolute area: r 5 0.7, p 5 0.001)
(Fig. 4). The Bland-Altman plot of the SPECT and MCE
perfusion defects is shown in Figure 5; the mean difference was
1.5 6 4.6%.
Discussion
NSRT is a promising novel treatment for HOCM. Because
it is desirable to limit the ethanol-induced infarction to the
septal segments causing the obstruction and to estimate the
planned infarct size, we used MCE in the present study. In our
preliminary series, MCE successfully mapped the myocardial
bed of the cannulated septal arteries and predicted the size of
Figure 3. MCE risk area versus peak CK levels in 29 study patients. Figure 4. MCE risk area versus SPECT perfusion defects in 23 study
patients.
Figure 5. Plot of the difference between SPECT and MCE perfusion
defects (PD) versus the average of both observations.
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the ensuing infarction with good accuracy when compared to
cardiac enzymes and nuclear perfusion defects.
Role of MCE during NSRT. In each case, MCE confirmed
the correct cannulation of the septal perforators of the LAD
and their occlusion by the angioplasty balloon without retro-
grade spillage. In some patients with an anomalous origin of
the septal perforators, definition of the myocardial distribution
of these arteries during NSRT becomes exceedingly important
to avoid the potential for inducing infarction in other regions.
Determination of the myocardial distribution of the septal
perforators is particularly important because of poor angio-
graphic resolution of the microcirculation and frequent over-
lap in the distribution of the septal arteries. We noted a
significant, albeit only moderate, correlation between the MCE
septal area and the reduction in LVOT gradient. In general,
when larger sections of the septum were infarcted, there were
large decrements in the outflow gradient. However, because
ethanol injection was directed mainly to the portion of the
septum causing the obstruction, many patients had small
defects with a large reduction in the gradient. Targeted
delivery of ethanol is of great potential importance in view of
the detrimental effects of large infarctions on left ventricular
function and the subsequent risks of ventricular arrhythmias
and complete heart block. MCE thus successfully guided
NSRT to induce the most effective septal infarction.
MCE risk area and prediction of infarct size after NSRT.
Previous studies in animals with myocardial infarction induced
by coronary occlusion showed that the risk area estimated by
MCE correlated with the extent of myocardial necrosis (9–11).
In these experiments, the contrast defect by MCE correlated
well with the infarct size assessed by triphenyl tetrazolium
chloride (r 5 0.84) (9). More recently, intracoronary injection
of sonicated ioxaglate in humans with acute myocardial infarc-
tion after reperfusion has allowed the prediction of functional
recovery (12) and the extent of myocardial necrosis, utilizing
the residual contrast defect immediately after reflow. In the
present study, to our knowledge the first to use MCE risk area
before controlled infarction in humans, we observed a strong
relation between the size of the infarction assessed by peak CK
levels and MCE risk area. Because the risk area was deter-
mined before occlusion of the coronary artery, the size of the
resulting infarction can be predicted a priori instead of after its
development.
Few studies have compared MCE and myocardial SPECT
scintigraphy. Previous work from our laboratory (13) showed
that in dogs with transient coronary occlusion, the perfusion
defect size correlates significantly with the contrast area at risk
(r 5 0.74). Our study compared in humans the MCE and
SPECT defects in the setting of an acute myocardial infarction.
Although there was generally good correlation between the
two techniques, the extent of spread may limit the prediction of
the SPECT defect size in an individual patient. Nevertheless,
in general MCE and SPECT appear to have equivalent roles in
the determination of risk area in acute coronary syndromes.
Our observations also illustrate the potential utility of this
technique in planned coronary interventions because the area
at risk (positive contrast) before angioplasty can be used to
delineate the jeopardized myocardium should acute occlusion
develop.
Conclusions. The present study represents an important
new application of MCE in the cardiac catheterization labora-
tory for patients with HOCM and validates the use of MCE
risk area during the procedure as a robust measure capable of
quantifying the ensuing infarct size.
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